Sample	Patient	Tissue_Timepoint	Tissue_Type	Treatment	Outcome	Age	BMI	PFS	Response	Response_SD	Order_actual	Order_desired	Tumor_T_cells
GADCHA_n1_TRA	GADCHA	n1	N	1	C	60	23.63403301	25.33	CB	CR	1	1	High
GADCHA_n2_TRA	GADCHA	n2	N	1	C	60	23.63403301	25.33	CB	CR	2	10	High
GADCHA_n3_TRA	GADCHA	n3	N	1	C	60	23.63403301	25.33	CB	CR	3	11	High
GADCHA_t1_TRA	GADCHA	t1	T	1	C	60	23.63403301	25.33	CB	CR	4	26	High
GADCHV_n1_TRA	GADCHV	n1	N	1	S	84	25.3125	10.41	CB	dSD	5	2	High
GADCHV_n2_TRA	GADCHV	n2	N	1	S	84	25.3125	10.41	CB	dSD	6	12	High
GADCHV_n3_TRA	GADCHV	n3	N	1	S	84	25.3125	10.41	CB	dSD	7	13	High
GADCHV_t1_TRA	GADCHV	t1	T	1	S	84	25.3125	10.41	CB	dSD	8	24	High
GADCJG_n1_TRA	GADCJG	n1	N	1	P	43	39.7749695	10.48	CB	PR	9	3	High
GADCJG_n2_TRA	GADCJG	n2	N	1	P	43	39.7749695	10.48	CB	PR	10	14	High
GADCJG_n3_TRA	GADCJG	n3	N	1	P	43	39.7749695	10.48	CB	PR	11	15	High
GADCJG_t1_TRA	GADCJG	t1	T	1	P	43	39.7749695	10.48	CB	PR	12	25	High
GADCJI_n1_TRA	GADCJI	n1	N	1	P	61	26.51299949	7.62	CB	PR	13	4	No_Tumor
GADCJI_n2_TRA	GADCJI	n2	N	1	P	61	26.51299949	7.62	CB	PR	14	16	No_Tumor
GADCMD_n1_TRA	GADCMD	n1	N	1	C	57	30.63153428	29.44	CB	CR	17	6	High
GADCMD_n2_TRA	GADCMD	n2	N	1	C	57	30.63153428	29.44	CB	CR	18	18	High
GADCMD_n3_TRA	GADCMD	n3	N	1	C	57	30.63153428	29.44	CB	CR	19	19	High
GADCMD_t1_TRA	GADCMD	t1	T	1	C	57	30.63153428	29.44	CB	CR	20	31	High
GADGCX_n1_TRA	GADGCX	n1	N	1	P	52	21.484375	10.91	CB	PR	21	7	High
GADGCX_n2_TRA	GADGCX	n2	N	1	P	52	21.484375	10.91	CB	PR	22	20	High
GADGCX_n3_TRA	GADGCX	n3	N	1	P	52	21.484375	10.91	CB	PR	23	21	High
GADGCX_t1_TRA	GADGCX	t1	T	1	P	52	21.484375	10.91	CB	PR	24	27	High
GADGCX_t2_TRA	GADGCX	t2	T	1	P	52	21.484375	10.91	CB	PR	25	29	High
GADGIZ_n1_TRA	GADGIZ	n1	N	1	P	70	31.80465416	3.48	CB	PR	28	9	Low
GADGIZ_n2_TRA	GADGIZ	n2	N	1	P	70	31.80465416	3.48	CB	PR	29	22	Low
GADGIZ_n3_TRA	GADGIZ	n3	N	1	P	70	31.80465416	3.48	CB	PR	30	23	Low
GADGIZ_t1_TRA	GADGIZ	t1	T	1	P	70	31.80465416	3.48	CB	PR	31	30	Low
